Abstract
Many immune responses are controlled by genes of the major histocompatibility complex (MHC). In humans these include the loci encoding the HLA-A,-B,-C,-DR,-DQ and-DP antigens, and many diseases have been linked with these. However, little information is available about any connection between malignant tumors and HLA. In this study the possible association of HLA-A,-B,-C and-DR specificities with susceptibilitities to malignant glioma was investigated in 42 patients with malignant glioma and 42 controls with non-glial intracranial tumors using the Terasaki-NIH standard method. The data were also compared with those of the 11th International HLA Workshop. The result showed that a high frequency of HLA-24(9) was observed in patients with intracranial malignant gliomas, which was not common in other, non-glial patient groups. In animals the MHC acts in defense against virally induced tumors, but until now there has been no evidence that they do so in human gliomas. Our discovery of its association with an HLA antigen is important for understanding the immunogenetic basis of susceptibility to glioma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Apuzzo MLJ, MS Mitchell: Immunobiological aspects of intrinsic glial tumors. J Neurosurg 55 (1981) 1–18
Benjamin R, P Parham: Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 11 (1990) 137–139
Blackman MA, JW Kappler, P Marrack: T-cell specificity and repertoire. Immunol Rev 101 (1988) 5–19
Burger PC, SB Green: Patient age, histological features and length of survival in patients with glioblastoma multiforme. Cancer 59 (1987) 1617–1625
Ebato M, T Nitta, H Yagita, K Sato, K Okumura: Skewed distribution of TCR Vα-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma. Immunol Lett 39 (1994) 53–64
Itoh K, CD Platsoucas, CM Balch: Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. J Exp Med 168 (1988) 1419–1441
Kampgen E, G Burz, R Wank: Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DGw3. Arch Dermatol 124 (1988) 1372–1375
Koenig UD, N Muller, KE Schneweis: Herpessimplex type-2 antibodies and HLA-B12 in cervical cancer. Lancet ii (1976) 857
Lopez de Castro JA: HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 10 (1989) 239–246
Marrack P, J Kappler: The T cell receptor. Science 238 (1987) 1073
Miceli MC, OJ Finn: cell receptor β-chain selection in human allograft rejection. J Immunol 142 (1989) 81–86
Muul LM; PJ Spiess, EP Director, SA Rosenberg: Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant glioma. J Immunol 138 (1987) 989–995
Nitta T, JR Oksenberg, NA Rao, L Steinman: Predominant expression of T cell receptor Vα7 in tumor infiltrating lymphocytes of uveal melanoma. Science 249 (1990) 672–674
Nitta T, K Sato, H Yagita, K Okumura, S Ishii: Preliminary trial of specific targeting therapy against malignant glioma. Lancet 335 (1990) 368–370
Panza NL, D Vecchio, M Maio, MD Felice, G Lombardi, M Minozzi, S Zappacosta: Tissue Antigen 20 (1992) 155–164
Riley E, O Olerup: HLA polymorphisms and evolution. Immunol Today 13 (1992) 333–335
Rittner G, G Schwanitz, MP Baur, CM Black, KI Welsh, P Kuhnl, C Rittner: Family studies in scleroderma demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes. Hum Genet 81 (1988) 64–70
Rosenberg SA: The development of new immunotherapies for the treatment of cancer using Interleukin-2. Ann Surg 208 (1988) 121–135
Rosenberg SA, P Spiess, R Lafrieniere: A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233 (1986) 1318–1321
Shapiro WR: Treatment of neuroectodermal brain tumors. Ann Neurol 12 (1982) 231–237
Takasugi M, PI Terasaki, B Henderson, MR Mickey, H Menck, RW Thompson: HLA-antigens in solid tumors. Cancer Res 33 (1973) 648–650
Terasaki PI, JD McClelland: Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998–1000
Terasaki PI, D Bernoco, MS Park, G Ozuturk, Y Iwaki: Microdroplet testing for HLA-A,-B,-C and-D antigens. Am J Clin Pathol 69 (1978) 103–118
Tsuji K, M Aizawa, T Sasazuki: HLA 1991, Proceeding of the 11th International Histocompatibility Workshop and Conference. Oxford Science Publications, W15.1 (1991) 1067–1166
Wank R, C Thomssen: High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352 (1990) 723–725
Weiss EH, A Ziegler: HLA-genes and function. Immunol Today 19 (1989) 516–518
Winoto A, JL Urban, NC Lan, J Goverman, L Hood, D Hansburg: Predominant use of a Vα gene segment in mouse T-cell receptors for cytochrome c. Nature 324 (1986) 679–682
Zulch KJ: Histological typing of tumors of the central nervous system. Geneva; Wordl Health Organization (1979) pp 160–172
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nitta, T., Ebato, M. & Sato, K. Association of malignant glioma with the human leukocyte antigen, HLA-A24(9). Neurosurg. Rev. 17, 211–215 (1994). https://doi.org/10.1007/BF00418435
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00418435